Company Description
NeuBelva Inc. is the brand owner of a highly effective scar management gel which provides visible improvement of scars and keloids. Scarnox was developed by a team of Canadian experts and is registered by Health Canada and FDA as a Class 1 Medical Device and has CE mark. NeuBelvas innovation of Quadri-Occlusion, which is a unique combination of f
NeuBelva Inc. occlusive agents, sets Scarnox apart from other scar gels.We are currently exporting Scarnox to several countries, and aim to make Scarnox a globally available product. As Scarnox is an over the counter (OTC) product, it is sold both in pharmacies and via other outlets.